859232-71-6Relevant articles and documents
INHIBITORS OF CD40-CD154 BINDING
-
Paragraph 00330; 00331; 00332, (2020/10/21)
Disclosed herein are compounds including pharmaceutically acceptable salts, esters, prodrugs, hydrates and tautomers thereof which modulate the interactions of CD-40-CD40L. The compounds are useful for treating, ameliorating or preventing an autoimmune disease, inflammatory disease, or other immune-related disease in a patient in need of treatment.
